封面图:Beyond Half-Life: Six Routes to Longer-Acting Peptide Therapeutics Extending the half-life of a peptide is not always the same as extending its therapeutic value. The more relevant development goal is to create an exposure profile that supports the intended pharmacology, dosing interval, and the
View More
Sichuan Pukang Pharmaceutical Phase II Facility Commissioned, Expanding Manufacturing Capacity for Long-Acting Peptide Raw Materials On May 15, 2026, the Phase II facility of Sichuan Pukang Pharmaceutical was officially completed and commissioned. Figure 1: Completion Ceremony for Phase II of Sichua
View More
Welcome to visit us at Shanghai&Milan CPHI in 2024!
View More